Deucravacitinib in plaque psoriasis: long-term safety and efficacy, M. Lebwohl et al.

Поділитися
Вставка
  • Опубліковано 15 кві 2024
  • Author video for 'Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase III POETYK trials'
    Full article: doi.org/10.109...

КОМЕНТАРІ •